Majdouline El Moussaoui

Dr. Majdouline El Moussaoui

University of Liège, Liège, Wallonia, Belgium
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2020 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
MMMajdouline El Moussaoui
Majdouline El Moussaoui
ILIseult Lambert
Iseult Lambert
NMNathalie Maes
Nathalie Maes
ASAnne-Sophie Sauvage
Anne-Sophie Sauvage
FFFrédéric Frippiat
Frédéric Frippiat
GDGilles Darcis
Gilles Darcis
Background: Polypharmacy and drug interactions are important issues for HIV-infected individuals. The number and nature of those interactions are continuously evolving with the use of new antiretroviral drugs and the aging of HIV-infected individuals. We aimed to analyze this evolution over time. Methods: This retrospective cohort study was conducted in the University Hospital of Liège (Belgium). Treatments of HIV-infected outpatients attending Liège University Hospital were collected and analyzed in 2012 and 2016. The University of Liverpool HIV drug interactions database was used to determine drug interactions. Results: We included 1038 patients in 2016, of whom 78% had 1 comedication. Polypharmacy was seen in 20% of the cohort. Four percent of the patients presented red flag interactions, and 38% had orange flag interactions. Nonantiretroviral (non-ARV) therapeutic classes involved in drug interactions were mostly cardiovascular and central nervous system drugs. They were followed by hormone drugs and dietary supplements for orange flag interactions. Two factors significantly contributed to both red and orange flag interactions: the number of non-ARV comedications and protease inhibitor–based ARV regimens. The proportion of patients with red or orange flag interactions remained stable from 2012 to 2016. Conclusions: This study highlights the persistence of an alarming number of contraindicated drug interactions and a high prevalence of potential drug interactions over time. Identification, prevention, and management of drug interactions remain a key priority in HIV care.

9 September 2022 in Journal of Infection
Verified
Journal Article
Closed access
MMMajdouline El Moussaoui
Majdouline El Moussaoui
SDSalomé Desmecht
Salomé Desmecht
ATAleksandr Tashkeev
Aleksandr Tashkeev
NLNicolas Lambert
Nicolas Lambert
NMNathalie Maes
Nathalie Maes
GDGilles Darcis
Gilles Darcis

6 July 2023 in Viruses
Verified
Journal Article
Open access
PDF file
NLNicolas Lambert
Nicolas Lambert
MMMajdouline El Moussaoui
Majdouline El Moussaoui
FBFrédéric Baron
Frédéric Baron
PMPierre Maquet
Pierre Maquet
GDGilles Darcis
Gilles Darcis
Opportunistic viral infections of the central nervous system represent a significant cause of morbidity and mortality among an increasing number of immunocompromised patients. Since antiviral treatments are usually poorly effective, the prognosis generally relies on the ability to achieve timely immune reconstitution. Hence, strategies aimed at reinvigorating antiviral immune activity have recently emerged. Among these, virus-specific T-cells are increasingly perceived as a principled and valuable tool to treat opportunistic viral infections. Here we briefly discuss how to develop and select virus-specific T-cells, then review their main indications in central nervous system infections, including progressive multifocal leukoencephalopathy, CMV infection, and adenovirus infection. We also discuss their potential interest in the treatment of progressive multiple sclerosis, or EBV-associated central nervous system inflammatory disease. We finish with the key future milestones of this promising treatment strategy.

26 April 2021 in British Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
NLNicolas Lambert
Nicolas Lambert
IHIsabelle Hansen
Isabelle Hansen
MMMajdouline El Moussaoui
Majdouline El Moussaoui
JGJean‐Baptiste Giot
Jean‐Baptiste Giot
CVChristelle Vercheval
Christelle Vercheval
PMPierre Maquet
Pierre Maquet

4 May 2021 in HIV Research & Clinical Practice
Verified
Journal Article
Closed access
MMMajdouline El Moussaoui
Majdouline El Moussaoui
NLNicolas Lambert
Nicolas Lambert
NMNathalie Maes
Nathalie Maes
KFKarine Fombellida
Karine Fombellida
DVDolores Vaira
Dolores Vaira
GDGilles Darcis
Gilles Darcis
Background: The COVID-19 pandemic and associated containment measures dramatically affected the health care systems including the screening of human immunodeficiency virus and the management people living with HIV around the world by making the access to preventive care services and specific medical monitoring more difficult. Objective: To study the impact of the COVID-19 pandemic on the holistic care of people living with HIV in Liège (Belgium). Methods: In this retrospective observational study conducted in Liège University Hospital, we compared the out-patient follow-up of HIV-infected individuals as well as the number of new HIV diagnoses between 2019 and 2020 and between the different waves of the COVID-19 pandemic in 2020. Results: In 2020, when compared to 2019, we observed a significant decrease in the number of new HIV diagnoses, especially during the first wave of the pandemic, and in the number of consultations undertaken by sexual health services, psychologists and specialists in infectious diseases at our HIV clinic. We also observed a decrease in the number of viral load assays and blood CD4 + T-cells count analyses performed, although we found less patients with HIV plasma viral load above 400 copies per mL in 2020. Finally, we noted a significant reduction in terms of screening of our HIV-infected patients for hepatitis C, syphilis, colorectal and anal cancers and hypercholesterolemia. Conclusions: Our experience exhibits the deleterious impact of the COVID-19 pandemic on the HIV care and the need to implement new strategies to guarantee its continuum.

12 July 2021 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
NLNicolas Lambert
Nicolas Lambert
MMMajdouline El Moussaoui
Majdouline El Moussaoui
PMPierre Maquet
Pierre Maquet